VRCA - Verrica Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRCA is currently covered by 3 analysts with an average price target of $43.24. This is a potential upside of $37.09 (603.09%) from yesterday's end of day stock price of $6.15.

Verrica Pharmaceuticals's activity chart (see below) currently has 55 price targets and 55 ratings on display. The stock rating distribution of VRCA is 80% HOLD and 20% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.86% with an average time for these price targets to be met of 61.1 days.

Highest price target for VRCA is $17, Lowest price target is $17, average price target is $17.

Most recent stock forecast was given by KEMP DOLLIVER from BROOKLINE on 18-Dec-2025. First documented stock forecast 10-Jul-2018.

Currently out of the existing stock ratings of VRCA, 4 are a HOLD (80%), 1 are a BUY (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Dec-2025

$17

$11.69 (220.15%)

2 months 22 days ago
(18-Dec-2025)

1/2 (50%)

$8.89 (109.62%)

78

Hold Since 05-Nov-2024

9 months 26 days ago
(14-May-2025)

2/7 (28.57%)

$90.9 (312.37%)

162

Hold Since 06-Nov-2024

11 months 4 days ago
(08-Apr-2025)

0/7 (0%)

$45.1 (47.52%)

Buy Since 22-Mar-2023

$30

$24.69 (464.97%)

$120

1 years 2 months 6 days ago
(06-Jan-2025)

0/4 (0%)

$23.26 (345.10%)

Hold Since 05-Nov-2024

$2

$-3.31 (-62.34%)

1 years 4 months 7 days ago
(05-Nov-2024)

1/5 (20%)

$-5.98 (-74.94%)

79

Show more analysts

Please expand the browser size to see the chart

What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?

On average it took 61.1 days on average for the stock forecasts to be realized with a an average price target met ratio 19.86

Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

SERGE BELANGER

Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?

Serge Belanger works at NEEDHAM and has 1 price targets and 4 ratings on VRCA

Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?

Ken Cacciatore with highest potential upside - $244.69

Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?

Gregory Renza with lowest potential downside - -$3.31

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?